Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be relevant for treating metastatic cancer. This is because actionable DNA errors remain remarkably stable over time, despite treatment with drugs. This discovery was made by Dutch researchers in a study led by the Netherlands Cancer Institute. The researchers used data from the Hartwig Medical Database for their research. They published their findings on August 9 online in the scientific journal Nature Medicine.

More information

You read an article in the category OncoAct. You may also be interested in Research, Scientific publications or Whole genome sequencing.
All news

Also read

Single WGS analysis of metastases is sufficient in most cases

Single WGS analysis of metastases is sufficient in most cases

26-10-2021

DNA analysis of the tumor is of crucial importance to determine treatment options for patients with metastasized lung cancer. But …

Whole Genome Sequencing feasible in clinical practice

Whole Genome Sequencing feasible in clinical practice

20-09-2020

Interim WIDE analysis gives researchers more confidence in a positive outcome. On 21 September 2020, Dr. Kim Monkhorst, who is a …

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

21-05-2021

Radiotherapy works by damaging the DNA of cancer cells. It’s an effective strategy overall, but many cancers have subsets of …

Would you like to be kept up to date with new developments?

Want to know more about the complete DNA test?

Visit OncoAct.nl